alveolar
macrophag
infect
pseudorabi
viru
prv
compar
noninfect
cytotox
foreign
transform
cell
product
interferon
ifn
five
prv
strain
use
infect
includ
strain
known
highli
virul
pig
ie
strain
strain
well
strain
regard
mild
nonvirul
ie
buk
bartha
multipl
infect
rang
tcidocel
target
cell
cytotox
assay
either
chicken
red
blood
cell
prvinfeet
vero
cell
human
myeloblastoma
cell
cell
line
producton
ifn
cultur
treat
polyinosin
polycytidyl
acid
poli
c
dilut
tissu
cultur
media
concentr
cultur
supernat
collect
variou
time
poststimul
test
antivir
activ
use
vesicular
stomat
viru
replic
inhibit
test
swine
abl
lyse
chicken
red
blood
cell
antibodyindepend
way
antibodydepend
way
wherea
lysi
prvinfect
vero
cell
accomplish
way
cytotox
chicken
red
blood
cell
reduc
prvinfect
compar
noninfeet
cell
particularli
infect
virul
prv
strain
specif
releas
valu
infect
strain
noninfect
valu
similarli
antibodydepend
cytotox
assay
prvinfect
vero
cell
activ
cell
product
ifn
readili
stimul
poli
c
optim
time
supernat
collect
h
poststimul
antivir
activ
abrog
treatment
supernat
antiserum
human
leukocyt
ifn
therefor
consid
due
interferonalpha
ifna
releas
macrophag
antivir
activ
present
supernat
prvinfeet
reduc
compar
noninfeet
differ
cultur
infect
virul
strain
prv
noninfect
cultur
statist
signific
p
result
provid
support
premis
role
lung
defens
compromis
prv
infect
de
macrophag
par
le
viru
de
la
maladi
daujeszki
viru
de
la
pseudorag
prv
en
anglai
ont
de
macrophag
non
au
niveau
de
leur
pouvoir
cytotoxiqu
pour
de
cellul
ou
et
au
niveau
de
la
ion
dinterf
cinq
souch
du
viru
prv
ont
pour
infect
le
macrophag
incluant
aussi
bien
de
souch
connu
pour
hautement
virulent
chez
le
porc
souch
et
souch
que
de
souch
comm
faiblement
ou
non
virulent
buk
et
bartha
linocul
de
cultur
de
dose
variabl
allant
de
tcidsacellul
le
cellul
cibl
dan
le
test
de
ont
soit
de
globul
roug
de
poulet
soit
de
cellul
de
la
cellulair
humain
pour
la
product
le
cultur
de
macrophag
ont
avec
de
racid
polyinosiniqu
polycytidyliqu
dart
le
milieu
de
cultur
une
concentr
de
author
correspond
ncsu
colleg
veterinari
medicin
hillsborough
street
raleigh
nc
usa
gerarix
igiesia
et
al
cellul
le
surnag
de
cultur
ont
de
temp
variabl
apr
la
stimul
et
test
pour
leur
activit
antiviral
en
utilis
le
test
dinhibit
de
replic
du
viru
de
la
stomatit
lc
macrophag
de
porc
ont
capabl
de
lyser
le
globul
roug
de
poulet
par
une
voie
anticorpsindpendant
mai
pa
par
une
voie
alor
que
la
lyse
de
cellul
de
la
vero
par
le
prv
pu
seffectu
par
le
deux
voi
le
macrophag
par
le
prv
se
sont
avert
moin
cytotoxiqu
pour
le
globul
roug
de
poulet
que
le
macrophag
non
pour
le
macrohag
alvdolair
par
le
souch
virulent
du
prv
souch
ou
le
valeur
de
du
r
aient
r
luit
de
et
contr
pour
le
macropbag
non
avec
le
cellul
de
la
ligne
vero
avec
le
prv
le
test
de
cytotoxicit
conduit
de
similair
n
avait
aucun
cytotoxiqu
de
macrophag
pour
le
cellul
la
product
ailment
par
traitement
de
cellul
avec
de
lacid
polycitidiliqu
le
moment
optim
pour
le
du
surnag
sest
entr
et
apr
la
stimul
et
antiviral
par
traitement
de
surnag
avec
un
antiserum
antiinterferon
de
leucocyt
humain
au
vu
de
ce
dolt
que
antiviral
est
due
une
product
par
le
macrophag
antiviral
dan
le
surnag
de
macrophag
alveolair
par
le
prv
tait
moindr
cell
de
macrophag
alveolair
non
la
differ
entr
le
cultur
de
macrophag
avec
de
souch
virulent
du
prv
et
le
cultur
de
macrophag
non
sest
signif
avec
une
p
ce
sont
autant
dargument
pour
que
le
de
macrophag
dan
le
pulmonair
peut
tre
compromi
par
une
infect
par
le
viru
de
la
maladi
daujeszki
mot
clef
viru
de
la
maladi
daujeszki
cytotoxicit
macrophag
alveolair
pseudorag
pseudorabi
viru
prv
also
known
aujeszki
diseas
viru
widespread
swine
pathogen
clinic
diseas
swine
vari
depend
age
anim
viru
strain
involv
gener
young
pig
prone
acut
diseas
high
mortal
rate
wherea
matur
anim
morbid
mortal
reduc
growingfinish
pig
diseas
often
includ
respiratori
problem
caus
either
viru
secondari
pathogen
pteurella
multocida
mycoplasma
hyopneumonia
alveolar
macrophag
consid
fundament
defens
respiratori
tract
particularli
bronchioli
alveoli
level
ciliat
epithelium
lack
activ
includ
phagocytosi
kill
bacteria
cytotox
infect
transform
cell
product
monokin
evid
pseudorabi
spread
wide
respiratori
tract
tonsil
alveolar
space
narita
et
al
report
find
prv
insid
tissu
section
intranasallyinocul
pig
addit
vitro
experi
shown
suscept
prv
infect
cell
less
capabl
carri
kill
activ
follow
phagocytosi
oxid
burst
import
activ
independ
phagocyt
activ
also
essenti
lung
clearanc
ie
secretori
activ
cytotox
transform
infect
foreign
cell
main
object
work
present
evalu
abil
prv
infect
lyse
foreign
infect
transform
cell
display
antivir
activ
known
prv
infect
eventu
kill
previous
report
infect
moi
effect
evalu
effector
cell
use
immedi
infect
wherea
h
postinfect
cell
viabil
reduc
difficult
compar
effici
prvinfect
noninfect
effector
cell
evalu
cytotox
synthesi
ifn
report
work
carri
immedi
infect
moi
use
chosen
way
time
assay
would
coincident
time
replic
spread
noninfect
cell
like
occur
target
cell
select
use
cytotox
assay
swine
leukocyt
mechan
recognit
destruct
activ
type
cell
presum
differ
alveolar
macrophag
collect
pig
lunglavag
follow
procedur
previous
describ
separ
mononuclear
cell
centrifug
sigma
cell
macrophag
indic
giemsa
differenti
stain
esteras
nonspecif
stain
cell
present
lunglavag
fluid
lymphocyt
cell
fibroblast
cell
cultur
plu
newborn
calf
serum
five
prv
strain
use
infect
prv
strain
use
includ
strain
known
virul
swine
strain
known
produc
clinic
diseas
pig
experiment
inocul
nonvirul
strain
use
buk
strain
bartha
strain
field
strain
also
use
origin
characterist
strain
previous
publish
viru
stock
produc
vero
cell
kept
use
cell
use
target
cytotox
assay
chicken
red
blood
cell
crbc
prvinfect
vero
cell
cell
human
myeloblastoma
cell
line
atcc
rockvil
md
case
label
carri
incub
na
cro
mci
per
cell
h
pig
anticrbc
hyperimmun
serum
prepar
immun
two
pig
intramuscularli
crbc
cell
mix
freund
incomplet
adjuv
pig
booster
week
first
immun
administ
cell
dilut
steril
pb
intraven
sera
collect
day
second
inocul
contain
anticrbc
hemagglutin
titer
pig
antiprv
collect
pig
vaccin
prv
use
commerci
avail
product
prvmarker
syntrovet
lenexa
kan
challeng
intranas
instil
prv
sera
collect
day
postchalleng
neutral
titer
prv
alveolar
macrophag
kept
overnight
complet
media
silicon
coat
tube
assess
viabil
trypan
blue
exclus
viabil
consist
cell
concentr
centrifug
infect
mock
infect
resuspend
pellet
cell
small
volum
hank
balanc
salt
solut
hbss
contain
requir
amount
viru
order
achiev
multipl
infect
moi
mock
infect
cell
resuspend
small
volum
hbss
viru
incub
min
fresh
hbss
ad
cell
pellet
nonadsorb
viru
discard
cell
resuspend
rpmi
nc
desir
concentr
antibodydepend
assay
target
cell
incub
variou
dilut
hyperimmun
sera
either
crbc
prv
min
incub
sera
dilut
requir
antibodyindepend
assay
final
effector
cell
either
prvinfect
noninfect
ad
case
incub
h
sever
control
two
assay
base
upon
antibodydepend
cytotox
includ
controlwel
peripher
blood
polymorphonuclear
cell
agematch
pig
assay
prvinfect
vero
cell
includ
controlwel
contain
noninfect
vero
cell
assay
includ
controlwel
peripher
blood
mononuclear
cell
agematch
pig
assay
includ
set
well
contain
media
target
cell
later
lyse
cytotox
valu
well
effector
cell
kind
provid
valu
spontan
lysi
incub
period
supernat
sampl
ml
collect
count
gamma
counter
specif
chromium
releas
calcul
describ
cell
five
differ
pig
use
test
repeat
least
four
time
differ
day
due
variat
condit
assay
result
present
individu
experi
preliminari
experi
show
cultur
treat
polyinosin
polycytidyl
acid
poli
c
cell
antivir
activ
supernat
collect
h
poststimul
activ
measur
reduct
plaqu
caus
vesicular
stomat
viru
vsv
vero
cell
antivir
activ
detect
supernat
nontreat
cultur
still
detect
dialysi
ph
buffer
h
follow
dialysi
ph
buffer
sinc
antivir
activ
satisfactorili
detect
primat
cell
limit
swine
cell
thu
consid
due
type
alpha
interferon
order
find
optimum
time
supernat
collect
well
whether
prv
infect
affect
synthesi
ifn
quantit
assess
antivir
activ
develop
follow
microtit
procedur
describ
pedersen
et
al
briefli
vero
cell
monolay
plate
microtit
plate
h
advanc
order
monolay
cell
alreadi
form
test
tissu
cultur
media
remov
mono
ayer
replac
cultur
supernat
dilut
tissu
cultur
media
lwell
cultur
incub
h
tissu
cultur
media
contain
vsv
ad
well
sampl
test
quadrupl
plate
six
well
supernat
sampl
viru
posit
virusinduc
cell
destruct
control
six
well
viru
cell
control
plate
incub
c
h
replic
vsv
within
cell
assess
dye
uptak
procedur
describ
everitt
wohlfart
plate
read
elisa
reader
use
nm
filter
valu
set
well
averag
valu
sampl
dilut
divid
valu
posit
control
viru
plot
dilut
notic
linear
curv
lost
high
low
dilut
consist
rang
dilut
result
report
calcul
valu
plot
valu
four
dilut
calcul
regress
line
test
use
also
evalu
antivir
activ
present
supernat
cultur
six
pig
supernat
evalu
react
antibodi
human
leukocyt
ifn
sigma
st
loui
mo
assess
prv
infect
upon
synthesi
ifn
carri
infect
cultur
made
plate
one
prv
strain
previous
mention
moi
x
left
uninfect
control
incub
period
allow
viru
adsorpt
h
viru
inoculum
remov
tissu
cultur
media
contain
poli
c
ad
well
mlwell
minimum
three
cultur
infect
strain
supernat
cultur
collect
poststimul
store
frozen
assay
potenti
presenc
infecti
prv
sampl
test
requir
neutral
viru
infect
accomplish
ad
pig
antiprv
sera
final
dilut
sampl
dilut
let
incub
least
h
test
sampl
vero
cell
media
contain
pig
serum
use
dilut
also
use
control
sampl
well
experi
repeat
five
differ
occas
use
cell
differ
pig
signific
differ
infect
noninfect
cell
determin
use
analysi
varianc
follow
complet
random
block
design
pig
one
block
cytotox
crbc
presenc
hyperimmun
serum
proport
invers
serum
dilut
higher
addit
neg
sera
indic
antibodydepend
cytotox
tabl
spontan
cytotox
crbc
present
fig
notic
prv
infect
less
effici
effector
target
ratio
use
total
five
experi
carri
count
per
minut
cpm
rang
total
releas
rang
infect
buk
higher
activ
compar
infect
still
chromium
releas
valu
record
noninfect
assay
carri
effector
target
ratio
chromium
releas
valu
noninfect
prvinfect
valu
cultur
infect
buk
respect
one
experi
hyperimmun
sera
dilut
signific
chang
result
notic
effector
target
ratio
variat
produc
differ
fig
cytotox
prvinfect
vero
cell
assay
carri
without
antibodi
reduc
compar
adcc
differ
perform
prvinfect
noninfect
better
seen
assay
carri
high
effector
target
cell
ratio
lower
ratio
activ
undetect
ratio
specif
cr
releas
noninfect
cell
cultur
infect
buk
valu
werc
zero
respect
cytotox
cell
time
cours
collect
supernat
use
evalu
antivir
activ
present
fig
notic
antivir
activ
first
detect
supernat
collect
h
poststimul
activ
peak
h
poststimul
incub
supernat
sampl
antibodi
reactiv
human
leukocyt
ifn
h
prior
test
reduc
antivir
activ
signific
reduct
ie
compar
nontreat
control
accomplish
antibodi
dilut
tabl
effect
prv
infect
upon
synthesi
ifnt
present
fig
supernat
cultur
infect
one
five
prv
strain
compar
supernat
noninfect
cultur
except
bartha
strain
strain
viru
strain
use
abl
caus
reduct
hour
stimul
poli
hc
fig
detect
antivir
activ
supernat
alveolar
macrophag
cultur
polyinosin
polycytidyl
acid
poli
c
ratio
protect
result
divid
mean
valu
sampl
well
mean
valu
controlwel
adjust
valu
obtain
sampl
dilut
consid
valu
neg
graph
show
mean
valu
obtain
cell
three
differ
pig
standard
deviat
amount
antivirai
activ
present
supernat
differ
protect
provid
cultur
infect
compar
noninfect
cultur
statist
signific
p
p
respect
result
present
show
swine
activ
crbc
antibodyindepend
assay
peripher
blood
polymorphonuclear
cell
show
posit
cytotox
valu
indic
antibodi
crbc
abl
mediat
adcc
activ
mechan
previous
report
result
show
adcc
activ
lung
cell
newborn
pig
crbc
carri
neutrophil
present
lunglavag
fluid
fact
mark
contrast
activ
sampl
newborn
pig
due
shift
cell
popul
mainli
neutrophil
newborn
pig
piglet
well
matur
anim
proport
neutrophil
lunglavag
cell
low
antibodydepend
cytotox
prvinfect
cell
describ
mani
type
effector
cell
includ
lunglavag
cell
l
l
elawar
hanh
compar
cell
young
pig
day
old
cell
matur
pig
found
popul
activ
adcc
case
prv
infect
effect
upon
activ
experi
compar
three
strain
viru
notic
similar
cytotox
crbc
strain
known
virul
caus
reduct
cytotox
antibodyindepend
cytotox
virusinfect
cell
describ
system
infect
calf
kidney
cell
destroy
lunglavag
cell
cattl
anoth
system
activ
describ
cell
infect
infecti
bovin
rihnotrach
viru
case
pseudorabi
known
lymphocyt
lunglavag
activ
prvinfect
cell
even
though
activ
much
lower
compar
peripher
blood
lymphocyt
highli
specif
virusinfect
cell
noninfect
cell
affect
fact
experi
activ
carri
lymphocyt
rule
unlik
main
activ
popul
proport
lymphocyt
effector
cell
popul
low
assum
low
rate
activ
even
though
infect
less
activ
compar
noninfect
low
valu
obtain
specif
releas
chromium
make
difficult
reliabl
assess
effect
prv
infect
upon
activ
quit
possibl
cultur
releas
varieti
cytokin
one
could
antivir
activ
preliminari
test
therefor
requir
antivir
activ
detect
supernat
cultur
induc
stimul
poli
c
resist
ph
restrict
homolog
cell
reduc
treatment
antibodi
human
leukocyt
ifn
known
cross
react
swine
ifnt
therefor
activ
consid
mainli
due
ifnct
activ
often
associ
ifn
well
main
criteria
evalu
induct
resist
viru
infect
howev
mani
activ
ifn
also
involv
phagocytosi
bacteria
blood
monocyt
enhanc
incub
cell
homolog
ifn
well
antibodydepend
cellular
cytotox
porcin
monocyt
porcin
render
less
permiss
african
swine
fever
viru
infect
treatment
bovin
ifn
clear
product
ifn
import
compon
surveil
role
carri
suggest
ifn
role
variat
virul
seen
among
herp
simplex
viru
hsv
strain
instanc
shimizu
et
al
compar
two
hsvl
variant
one
abl
caus
lethal
infect
mice
caus
lethal
infect
replic
cultur
latter
inhibit
antihsv
antibodi
highli
sensit
mous
ifn
differ
experi
brucher
et
al
compar
replic
hsv
cell
suscept
nonsuscept
mice
found
monocyt
suscept
mice
support
viru
replic
readili
produc
less
ifn
compar
monocyt
hsvresist
mice
case
prv
report
attenu
strain
sensit
ifn
better
ifn
induc
compar
virul
strain
experi
report
compar
sensit
ifn
inde
signific
differ
strain
abil
lessen
synthesi
ifn
cell
stimul
poli
c
strain
known
produc
acut
diseas
swine
abl
reduc
synthesi
ifn
effect
caus
strain
statist
signific
differ
seen
either
cytotox
antivir
activ
prvinfect
noninfect
unlik
sole
due
dispar
viabl
cell
cultur
previou
experi
shown
cultu
infect
low
moi
decreas
number
viabl
cell
much
higher
period
h
compar
first
h
postinfect
lglesia
et
al
unpublish
result
perhap
due
period
requir
dissemin
progeni
viru
rational
use
low
moi
compar
activ
prvinfect
noninfect
immedi
infect
consid
differ
viabil
rate
result
present
show
prv
infect
virul
prv
strain
deleteri
effect
upon
defens
activ
carri
alveolar
macrophag
experi
perform
cell
retriev
calv
experiment
infect
bovin
herp
viru
yield
similar
result
knowledg
perform
swine
infect
pig
prv
lack
research
need
order
know
extent
sever
impair
caus
prv
infect
natur
infect
pig
